Cabazitaxel (Jevtana)

 

Xi'an Huawave Biotech Co., Ltd. is a professional Cabazitaxel manufacturer and Cabazitaxel supplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
Xi'an Huawave Biotech Co., Ltd. is a professional Cabazitaxel manufacturer and Cabazitaxel supplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
Cabazitaxel is a pharmaceutical raw material, and its main active ingredient is also Kabatasis, which has significant anti-cancer effects. The following is a detailed explanation of the efficacy of Cabazitaxel:
1、 Anti cancer mechanism
Cabazitaxel belongs to the Taxane class of drugs, which inhibit cancer cell division and growth by affecting the microtubule structure of cells. Specifically, Kabatasis can bind to free microtubules, promote microtubule assembly into stable microtubules, and inhibit their depolymerization. This mechanism of action leads to the formation of a large number of dysfunctional microtubule bundles within the cell, which in turn destroys the microtubule network structure of the cell, effectively blocking the cell's mitotic process and preventing mutant cells from proliferating effectively.
2、 Main benefits
Prostate cancer treatment: Cabazitaxel has been widely used to treat advanced prostate cancer, especially for patients who have developed resistance to chemotherapy. It is the first chemotherapy drug proven to prolong patient survival in CRPC (hormone refractory prostate cancer) after failure of docetaxel, and therefore also serves as a second-line treatment for CRPC.
Breast cancer treatment: Cabazitaxel is also used as a treatment option for breast cancer, and is usually used together with other drugs to play a synergistic anti-cancer role.
Other cancer treatment: In addition to prostate cancer and breast cancer, Cabazitaxel also plays a role in other types of cancer treatment, such as esophageal cancer, lung cancer, etc. This demonstrates its broad anti-cancer spectrum and clinical application value.
3、 Precautions for use
Target audience: Cabazitaxel is suitable for patients who have previously received treatment regimens containing docetaxel and can be used in combination with prednisone to treat mCRPC. However, not all patients are suitable for using cabataside. It is contraindicated for patients who are allergic to Cabazitaxel, have severe liver dysfunction, and have a neutrophil count ≤ 1500/mm ³.
Adverse reactions:Cabazitaxel can inhibit bone marrow hematopoietic function, thereby reducing the number of white blood cells. During the treatment period, regular monitoring of blood routine is necessary. If a decrease in white blood cells is detected, timely measures such as leukocyte boosting therapy should be taken. In addition, common adverse reactions include anemia, diarrhea, nausea, fatigue, weakness, vomiting, hematuria, constipation, decreased appetite, back pain, and abdominal pain. Patients over 65 years old are more prone to certain adverse reactions, including neutropenia and febrile neutropenia.

1、 Main purpose
Prostate cancer treatment: Cabazitaxel is widely used to treat advanced prostate cancer, especially those who have already received chemotherapy and developed drug resistance. It is the first chemotherapy drug proven to prolong the survival of hormone refractory prostate cancer (CRPC) patients after failed treatment with docetaxel, and therefore is also considered a second-line treatment for CRPC.
Breast cancer treatment: Cabazitaxel is also used as a treatment option for breast cancer, and is usually used in combination with other drugs to improve the treatment effect.
Other cancer treatment: In addition to prostate cancer and breast cancer, Cabazitaxel also plays a role in other types of cancer treatment, such as esophageal cancer, lung cancer, etc. This is due to its ability to interfere with the microtubule structure of tumor cells, prevent cell division, and thus slow down the growth and spread of cancer.
2、 Drug characteristics
Chemical structure: Cabazitaxel is a semi synthetic small molecule compound of the taxane class, with a unique chemical structure that allows it to specifically act on microtubule structures within cancer cells.
Mechanism of action:Cabazitaxel binds to microtubule proteins, promoting their assembly into microtubules and preventing the disassembly of already assembled microtubules, thereby maintaining microtubule stability. This stabilizing effect further inhibits cell mitosis and the function of interphase cells, thereby achieving anti-cancer effects.
Metabolism and excretion: Cabazitaxel is widely metabolized in the liver (>95%), mainly by CYP3A4/5 isoenzymes, producing various metabolites. Its plasma protein binding rate is 80%, indicating that it has high stability in the blood.
3、 Precautions for use
Medication guidance: Cabazitaxel is usually used in combination with drugs such as prednisone or prednisolone to enhance treatment efficacy. When using, one should strictly follow the doctor's medication guidance to ensure the safety and effectiveness of the medication.
Monitoring and evaluation: During the treatment process, the patient's condition should be regularly monitored to evaluate the treatment effect, and the treatment plan should be adjusted according to the actual situation.
Adverse reactions: Although Cabazitaxel has high efficacy in treating cancer, it may also cause some adverse reactions such as neutropenia, anemia, fatigue, diarrhea, etc. Therefore, close attention should be paid to the adverse reactions of patients during use, and corresponding measures should be taken in a timely manner.
In summary, Cabazitaxel is a drug with broad prospects for anti-cancer applications, particularly suitable for the treatment of advanced or drug-resistant cancers. However, attention should also be paid to the possible adverse reactions and medication precautions during use to ensure patient safety and treatment effectiveness.